240
Participants
Start Date
October 7, 2021
Primary Completion Date
February 28, 2025
Study Completion Date
February 28, 2025
Patients treated for their lung cancer.
"In addition to the weekly Moovcare® Lung follow-up, patients will benefit from standard oncological follow-up at the discretion of their oncologist according to standard recommendations for 2 years. Questionnaires will be completed at different times as mentioned below on the global study scheme and Flowchart.~In an active treatment situation, the pace of consultations will be adapted to the pace of treatment administration, according to standard recommendations. It may be lengthened in the absence of a clinical application or biological alert at the discretion of the investigator."
AP-HM La Timone, Marseille
Clinique mutualiste de l'ESTUAIRE, Saint-Nazaire
Centre Hospitalier Public du Cotentin, Cherbourg
Hopital Robert Schumann, Vantoux
Centre Oscar Lambret, Lille
CHU de PAU, Pau
Nouvel Hôpital Civil, Strasbourg
Hôpital Nord-Ouest, Gleizé
Institut Curie, Paris
Hôpital Forcilles, Férolles-Attilly
Polyclinique de Limoges - Site de François CHENIEUX, Limoges
Institut Curie, Saint-Cloud
Hopital Franco Britannique, Levallois-Perret
Chu Argenteuil, Argenteuil
Clinique Saint-George, Nice
Institut Curie
OTHER